Ranbaxy Laboratories Ltd’s managing director and chief executive officer Atul Sobti will step down from his positions effective Aug 19.
Arun Sawhney,who is currently president of Ranbaxy’s global pharmaceutical business,will take over as managing director,Daiichi Sankyo-controlled Ranbaxy said in a statement.
Sobti is stepping down after just over a year in the top spot. No reason was given for his departure.


